Shine-On BioMedical Co.,Ltd. (6926.TWO) stock: key figures, P/E, revenue and dividend

Health Care · Taiwan · ISIN TW0006926009

Price
55.90 TWD
Market cap
2.78 bn TWD
P/E (2025)
–
P/S (2025)
92.79
Dividend yield
0.00 %
Net margin
-367.62 %
Return on equity (ROE)
-12.16 %
Return on assets (ROA)
-11.60 %

Shine-On BioMedical Co.,Ltd. financials

Fiscal year20242025
Revenue0.00 TWD30.00 m TWD
Gross profit-2.19 m TWD30.00 m TWD
Operating income-136.07 m TWD-125.50 m TWD
EBIT-118.57 m TWD-110.39 m TWD
Net income-118.89 m TWD-110.29 m TWD
Diluted EPS – continuing operations-2.39 TWD-2.21 TWD

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. Shine-On BioMedical Co.,Ltd. was founded in 2011 and is based in Taichung, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.